Lipid-Based Liquid Crystals As Carriers for Antimicrobial Peptides: Phase Behavior and Antimicrobial Effect.

The number of antibiotic-resistant bacteria is increasing worldwide, and the demand for novel antimicrobials is constantly growing. Antimicrobial peptides (AMPs) could be an important part of future treatment strategies of various bacterial infection diseases. However, AMPs have relatively low stability, because of proteolytic and chemical degradation. As a consequence, carrier systems protecting the AMPs are greatly needed, to achieve efficient treatments. In addition, the carrier system also must administrate the peptide in a controlled manner to match the therapeutic dose window. In this work, lyotropic liquid crystalline (LC) structures consisting of cubic glycerol monooleate/water and hexagonal glycerol monooleate/oleic acid/water have been examined as carriers for AMPs. These LC structures have the capability of solubilizing both hydrophilic and hydrophobic substances, as well as being biocompatible and biodegradable. Both bulk gels and discrete dispersed structures (i.e., cubosomes and hexosomes) have been studied. Three AMPs have been investigated with respect to phase stability of the LC structures and antimicrobial effect: AP114, DPK-060, and LL-37. Characterization of the LC structures was performed using small-angle X-ray scattering (SAXS), dynamic light scattering, ζ-potential, and cryogenic transmission electron microscopy (Cryo-TEM) and peptide loading efficacy by ultra performance liquid chromatography. The antimicrobial effect of the LCNPs was investigated in vitro using minimum inhibitory concentration (MIC) and time-kill assay. The most hydrophobic peptide (AP114) was shown to induce an increase in negative curvature of the cubic LC system. The most polar peptide (DPK-060) induced a decrease in negative curvature while LL-37 did not change the LC phase at all. The hexagonal LC phase was not affected by any of the AMPs. Moreover, cubosomes loaded with peptides AP114 and DPK-060 showed preserved antimicrobial activity, whereas particles loaded with peptide LL-37 displayed a loss in its broad-spectrum bactericidal properties. AMP-loaded hexosomes showed a reduction in antimicrobial activity.

[1]  S. Lesieur,et al.  Multicompartment lipid cubic nanoparticles with high protein upload: millisecond dynamics of formation. , 2014, ACS nano.

[2]  M. Monduzzi,et al.  Addition of hydrophilic and lipophilic compounds of biological relevance to the monoolein/water system. I. Phase behavior. , 2001, Chemistry and physics of lipids.

[3]  K. Edwards,et al.  Cryo transmission electron microscopy of liposomes and related structures , 2000 .

[4]  M. Almgren,et al.  Cubic Lipid−Water Phase Dispersed into Submicron Particles , 1996 .

[5]  F. Tiberg,et al.  A combined in vitro and in vivo study on the interactions between somatostatin and lipid-based liquid crystalline drug carriers and bilayers. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[6]  L. M. Carrasco,et al.  Novel Formulations for Antimicrobial Peptides , 2014, International journal of molecular sciences.

[7]  S. Salentinig,et al.  A novel approach to enhance the mucoadhesion of lipid drug nanocarriers for improved drug delivery to the buccal mucosa. , 2014, International journal of pharmaceutics.

[8]  S. Lesieur,et al.  Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery. , 2011, Accounts of chemical research.

[9]  A. Angelova,et al.  Interaction of the peptide antibiotic alamethicin with bilayer- and non-bilayer-forming lipids: influence of increasing alamethicin concentration on the lipids supramolecular structures. , 2000, Archives of biochemistry and biophysics.

[10]  C. Drummond,et al.  Lyotropic liquid crystal engineering-ordered nanostructured small molecule amphiphile self-assembly materials by design. , 2012, Chemical Society reviews.

[11]  M. Caffrey,et al.  The phase diagram of the monoolein/water system: metastability and equilibrium aspects. , 2000, Biomaterials.

[12]  K. Edwards,et al.  PEG-stabilized lipid disks as carriers for amphiphilic antimicrobial peptides. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[13]  B. Sarmento,et al.  Lipid-based colloidal carriers for peptide and protein delivery – liposomes versus lipid nanoparticles , 2007, International journal of nanomedicine.

[14]  T. Rades,et al.  Comparative study of liposomes, transfersomes, ethosomes and cubosomes for transcutaneous immunisation: characterisation and in vitro skin penetration , 2012, The Journal of pharmacy and pharmacology.

[15]  B. Boyd.  Characterisation of drug release from cubosomes using the pressure ultrafiltration method. , 2003, International journal of pharmaceutics.

[16]  Søren Neve,et al.  Plectasin, a Fungal Defensin, Targets the Bacterial Cell Wall Precursor Lipid II , 2010, Science.

[17]  L. Sagalowicz,et al.  Self-assembled structures and pKa value of oleic acid in systems of biological relevance. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[18]  F. Hu,et al.  Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles , 2009, International journal of nanomedicine.

[19]  Ali Hossain Khan,et al.  Phase Behavior and Aggregate Formation for the Aqueous Monoolein System Mixed with Sodium Oleate and Oleic Acid , 2001 .

[20]  H. Bysell,et al.  Lipid-based nanoformulations for peptide delivery. , 2016, International journal of pharmaceutics.

[21]  R. Eckert.  Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development. , 2011, Future microbiology.

[22]  L. Domingues,et al.  Wound healing activity of the human antimicrobial peptide LL37 , 2011, Peptides.

[23]  T. Rades,et al.  Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[24]  R. Hancock,et al.  Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.

[25]  A. Zimmer,et al.  Glycerol monooleate liquid crystalline phases used in drug delivery systems. , 2015, International journal of pharmaceutics.

[26]  S. Lesieur,et al.  Earliest stage of the tetrahedral nanochannel formation in cubosome particles from unilamellar nanovesicles. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[27]  T. Rades,et al.  Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems , 2012, Journal of liposome research.

[28]  P. Ma,et al.  Cubic and Hexagonal Liquid Crystals as Drug Delivery Systems , 2014, BioMed research international.

[29]  A. Schmidtchen,et al.  Evaluation of Strategies for Improving Proteolytic Resistance of Antimicrobial Peptides by Using Variants of EFK17, an Internal Segment of LL-37 , 2008, Antimicrobial Agents and Chemotherapy.

[30]  N. K. Jain,et al.  Enhanced Oromucosal Delivery of Progesterone Via Hexosomes , 2007, Pharmaceutical Research.

[31]  A. Angelova,et al.  Proteocubosomes: nanoporous vehicles with tertiary organized fluid interfaces. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[32]  S. Lesieur,et al.  Protein entrapment in PEGylated lipid nanoparticles. , 2013, International journal of pharmaceutics.

[33]  Olivier Taboureau,et al.  Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus , 2005, Nature.

[34]  Christer Svensson,et al.  The yellow mini-hutch for SAXS experiments at MAX IV Laboratory , 2013 .

[35]  K. Larsson.  Cubic lipid-water phases: structures and biomembrane aspects , 1989 .

[36]  M. Almgren,et al.  Submicron Particles of Reversed Lipid Phases in Water Stabilized by a Nonionic Amphiphilic Polymer , 1997 .

[37]  M. Fantini,et al.  Reverse Hexagonal Phase Nanodispersion of Monoolein and Oleic Acid for Topical Delivery of Peptides: in Vitro and in Vivo Skin Penetration of Cyclosporin A , 2006, Pharmaceutical Research.

[38]  A. Angelova,et al.  Structural organization of proteocubosome carriers involving medium- and large-size proteins , 2005 .

[39]  S. Hoffmann,et al.  Protein-containing PEGylated cubosomic particles: freeze-fracture electron microscopy and synchrotron radiation circular dichroism study. , 2012, The journal of physical chemistry. B.

[40]  T. Rades,et al.  Bicontinuous cubic liquid crystals as sustained delivery systems for peptides and proteins , 2010, Expert opinion on drug delivery.

[41]  S. Lesieur,et al.  Dynamic control of nanofluidic channels in protein drug delivery vehicles , 2008 .

[42]  F. Tiberg,et al.  Cubic phase nanoparticles (Cubosome): principles for controlling size, structure, and stability. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[43]  D M Chilukuri,et al.  Cubic phase gels as drug delivery systems. , 2001, Advanced drug delivery reviews.

[44]  Martin Caffrey,et al.  The Temperature-Composition Phase Diagram and Mesophase Structure Characterization of the Monoolein/Water System , 1996 .

[45]  Shuguang Zhang,et al.  Tuning Curvature and Stability of Monoolein Bilayers by Designer Lipid-Like Peptide Surfactants , 2007, PloS one.

[46]  A. Schmidtchen,et al.  Antimicrobial peptides: key components of the innate immune system , 2012, Critical reviews in biotechnology.

[47]  I. Kwon,et al.  Self-assembled “nanocubicle” as a carrier for peroral insulin delivery , 2002, Diabetologia.